Safety Medical Of Australia Hits Trading Suspension Due To Losses
This article was originally published in PharmAsia News
Australia's Safety Medical, which makes medical syringes as well as other devices, has been suspended for trading on the Australian Securities Exchange. Safety Medical group, which includes Safety Medical Products, makers of syringes, failed to get the financial support it had sought from banking institutions. At the same time, Safety Medical is seeking to buy a 40 percent stake in Hungarian drug maker Dispomedicor. (Click here for more
You may also be interested in...
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
The UK's Celleron has attracted a "blue chip suite of investors" to an Irish-domiciled spin-off based on the potential of Roche-developed emactuzumab for TGCT, a debilitating orphan disease that causes joint damage and has limited clinical options.
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.